Kayla Garrett: Improving Haemophilia A Care Beyond Bleed Prevention
Kayla Garrett, Senior Talent Acquisition Partner at Roche, shared a post on LinkedIn:
“At the heart of every discussion about the future of haemophilia A is the recognition that redefining care goes beyond medicine – it is about looking at patients’ whole lives, protecting joint health, and easing the daily anxieties that families carry across generations.
At Roche, we believe that even one bleed is one too many, especially for a condition like haemophilia A that is for life.
We are profoundly grateful to the dedicated clinicians, researchers, and patient organisations who partner with us every day.
Together, we are raising the bar to turn scientific progress into a new reality.
Find out more about our efforts in haemophilia A on our website.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Jul 29, 2026, 16:30Mostafa Faisal: Impact of DNMT3A and TET2 Mutations on Clotting and Bleeding in PV and ET
-
Jul 29, 2026, 16:01Gerardo Moscatelli: The Spike Protein Cascade – From Endothelial Binding to Vascular Collapse
-
Jul 29, 2026, 15:42Julie Cardoso: FDA Clears the First AI-Guided Ultrasound Software for Suspected DVT
-
Jul 29, 2026, 15:26Ahmad Alkhammash: Completing an Advanced Fellowship in Adult Thrombosis Medicine
-
Jul 29, 2026, 15:13Yara Mahmoud: The Molecular Basis in Hematology
-
Jul 29, 2026, 15:11Louisa Jorm: A New Era of Dynamic Cardiovascular Risk Assessment
-
Jul 29, 2026, 15:04Filippo Consonni: Treatment Strategies for Hematologic Immune Dysregulation in Inborn Errors of Immunity
-
Jul 29, 2026, 14:53Samer Alsaid: Warfarin Outcomes Reassessed Through COMBINE AF
-
Jul 29, 2026, 14:46François Saller: TFPI-Targeting VHHs for Haemophilia and Rare Bleeding Disorders